Literature DB >> 22129561

Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation.

Shozo Honda1, Shigeko Satomura, Shin Hayashi, Issei Imoto, Eiji Nakagawa, Yu-ichi Goto, Johji Inazawa.   

Abstract

Investigations of chromosomal rearrangements in patients with mental retardation (MR) are particularly informative in the search for genes involved in MR. Here we report a family with concomitant duplications of methyl CpG binding protein 2 (MECP2) at Xq28 and ATRX (the causative gene for X-linked alpha thalassemia/mental retardation) at Xq21.1 detected by array-comparative genomic hybridization. The alterations were observed in a 25-year-old man who inherited them from his mother, who showed a normal phenotype and completely skewed X-chromosome inactivation, and also in his cousin, a 32-year-old man. The proband and his cousin showed severe MR, muscular hypotonia, recurrent respiratory infections and various other features characteristic of MECP2 duplication syndrome. However, the proband also had cerebellar atrophy never reported before in MECP2 duplication syndrome, suggesting that his phenotypes were modified through the ATRX duplication in an additive or epistatic manner.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22129561     DOI: 10.1038/jhg.2011.131

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  7 in total

Review 1.  Histone methylation: a dynamic mark in health, disease and inheritance.

Authors:  Eric L Greer; Yang Shi
Journal:  Nat Rev Genet       Date:  2012-04-03       Impact factor: 53.242

Review 2.  Epigenetic contributions to hormonally-mediated sexual differentiation of the brain.

Authors:  M M McCarthy; B M Nugent
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

3.  Clinical and molecular genetic characterization of familial MECP2 duplication syndrome in a Chinese family.

Authors:  Xiaoyan Li; Hua Xie; Qian Chen; Xiongying Yu; Zhaoshi Yi; Erzhen Li; Ting Zhang; Jian Wang; Jianmin Zhong; Xiaoli Chen
Journal:  BMC Med Genet       Date:  2017-11-15       Impact factor: 2.103

4.  Infectious and immunologic phenotype of MECP2 duplication syndrome.

Authors:  Michael Bauer; Uwe Kölsch; Renate Krüger; Nadine Unterwalder; Karin Hameister; Fabian Marc Kaiser; Aglaia Vignoli; Rainer Rossi; Maria Pilar Botella; Magdalena Budisteanu; Monica Rosello; Carmen Orellana; Maria Isabel Tejada; Sorina Mihaela Papuc; Oliver Patat; Sophie Julia; Renaud Touraine; Thusari Gomes; Kirsten Wenner; Xiu Xu; Alexandra Afenjar; Annick Toutain; Nicole Philip; Aleksandra Jezela-Stanek; Ludwig Gortner; Francisco Martinez; Bernard Echenne; Volker Wahn; Christian Meisel; Dagmar Wieczorek; Salima El-Chehadeh; Hilde Van Esch; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2015-02-27       Impact factor: 8.317

Review 5.  A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.

Authors:  Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2022-03-21       Impact factor: 4.123

6.  MECP2 duplication phenotype in symptomatic females: report of three further cases.

Authors:  Francesca Novara; Alessandro Simonati; Federico Sicca; Roberta Battini; Simona Fiori; Annarita Contaldo; Lucia Criscuolo; Orsetta Zuffardi; Roberto Ciccone
Journal:  Mol Cytogenet       Date:  2014-01-28       Impact factor: 2.009

7.  Microarray-based ultra-high resolution discovery of genomic deletion mutations.

Authors:  Eric J Belfield; Carly Brown; Xiangchao Gan; Caifu Jiang; Dilair Baban; Aziz Mithani; Richard Mott; Jiannis Ragoussis; Nicholas P Harberd
Journal:  BMC Genomics       Date:  2014-03-22       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.